Gain Therapeutics, Inc. (GANX): Insider Trading, Congress Trades & Research | Tormere

GANX

$1.15+1.77%visit website

Gain Therapeutics, Inc.

Market Cap

$50M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.25

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

4.4

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Jun 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	2,850	2,347	2,763	2,138	10,098
Total operating expenses	4,786	4,466	5,354	4,682	19,287
Operating income	(4,786)	(4,466)	(5,354)	(4,682)	(19,287)
Pretax income	(4,735)	(4,467)	(5,426)	(4,572)	(19,200)
Income tax	549	70	183	104	907
Net income	(5,284)	(4,538)	(5,609)	(4,676)	(20,106)
EPS (basic) ($)	(0.15)		(0.13)	(0.11)	—
EPS (diluted) ($)	(0.15)		(0.13)	(0.11)	—
Weighted avg. shares (basic)	34,998		42,230	42,880
Weighted avg. shares (diluted)	34,998		42,230	42,880

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 11, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 22 more quarters, back to Mar 2020, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

GANX May 2027 5.000 put (GANX270521P00005000) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-11-01

Gain Therapeutics Stock Price Forecast. Should You Buy GANX?

StockInvest.us · 2026-10-30

An officer receives 130,000 Gain Therapeutics (GANX) stock options with a $1.19 exercise price.

Stock Titan · 2026-10-30

GANX May 2027 5.000 put (GANX270521P00005000) stock price, news, quote and history

Yahoo Finance UK · 2026-10-29

Gain Therapeutics to Attend the 2026 Maxim Growth Summit

Yahoo · 2026-10-08

HC Wainwright & Co. Reiterates Buy on Gain Therapeutics, Maintains $8 Price Target

Benzinga · 2026-10-05

BTIG reiterates Buy on Gain Therapeutics stock on trial data

Investing.com · 2026-10-05

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

Yahoo Finance · 2026-10-01

Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders

Yahoo Finance · 2026-09-29

Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference

Yahoo Finance · 2026-09-17

Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference

Yahoo Finance · 2026-08-25

Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update

Yahoo Finance · 2026-07-16

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

Yahoo Finance · 2026-06-29

Why Is GANX Stock Rallying 22% After Hours?

Stocktwits · 2026-06-29

GANX Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-25

Informational purposes only, not investment advice.